- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
Last year, WCAG, People’s Action and many others joined together to ask for and rally for the use of march-in-rights to lower prescription drug costs. We demonstrated outside of the Health and Human Services (HHS) offices in DC, urging President Biden and HHS Secretary Xavier Becerra to use March-In-Rights and other existing executive authorities to break pharmaceutical monopolies, increase competition and production, and lower costs for prescription drugs at their core. Video of the action is available on our YouTube Channel.
On October 16, 2023, Public Citizen, WVCAG and over 30 allies wrote to Secretary Becerra and US Commerce Secretary Gina Raimondo, urging them to advance the interagency review of march-in rights without delay.
The groups’ letter comes after earlier this year, Secs. Raimondo and Becerra announced a whole-of-government review of march-in rights, including when to exercise them based on prices. This review has the potential to reorient administration policy to help put an end to big pharma price gouging of prescription drugs invented with the support of taxpayer dollars and to instead make these medicines affordable to everyone.
I can’t help but think that we might have helped in nudging the HHS and President Biden in the right direction.
